北米の臨床文書改善 (CDI) 市場 (2022年)：Frost Radar

従来のEMR企業、CDIベンダー、従来のHITベンダーが、一元化されたプラットフォームでソリューションと機能を提供しようと競合し、M&Aが活発化するため、今後3～5年の間に、CDI市場は大きく統合されると予想されています。また、ポストパンデミックケア、遠隔医療、バーチャルケアに焦点を当てた慢性疾患管理を中心とした潜在的な規制の影響もCDIの成長をさらに押し上げる見通しです。

当レポートでは、北米の臨床文書改善 (CDI) の市場を調査し、市場概要、主要企業のプロファイル、Frost Radar独自の評価基準に基づく参入事業者のベンチマーキング分析などまとめています。

目次

戦略的必須要件および成長環境

• 戦略的必須要件
• 成長環境
• 北米のCDI市場：主要企業

Frost Radar (TM)

• フロストレーダー (TM) ：臨床文書の改善
• フロストレーダー (TM) ：競合環境

C2A (主要企業)

• 3M Health Information Systems
• Arintra
• Cerner
• Chartwise
• EZDI (an AGS Health company)
• Greenway Health
• Nuance (part of Microsoft)
• Optum
• R1 RCM
• Waystar

戦略的洞察

次のステップ

Frost Radar (TM) アナリティクス

• Frost Radar (TM) ：将来の成長の可能性のベンチマーキング
• 免責事項

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient's care, facilitates accurate reimbursement, and ensures compliance risk management and revenue integrity. With growing automation and digitalization in the healthcare space, legacy CDI solution providers are not able to evolve with payers' ever-changing regulatory requirements for clinical documentation and coding.

Solution providers are reimagining tools that pave the way for next-generation clinical documentation across the healthcare continuum. The emphasis on detailed clinical documentation and coding will be paramount to personalized treatments, preventing adverse effects (medical reconciliation, hospital-acquired infections, clinical trial mismatches) and optimizing the clean claims rate. As a result, the contribution of various CDI solutions to the overarching RCM portfolio is forecast to increase from 20% in 2020 to 33% in 2024. Regulators prioritize digitally-enabled clinical documentation as they move away from legacy approaches of assessing gaps in payment cycles (clinical documentation after treatment) and aim for transparency, accuracy, and specificity of fund utilization in annual budgets and push for more proactive population health management and prioritized disease-specific CDI. There is a clear need for automation and analytics-based CDI management solutions that leverage the power of machine learning (ML) and artificial intelligence (AI) to achieve regulatory compliance, virtual assistant technology, natural language processing, clinical decision support, and assist with timely decision-making for proper reimbursement and reduce physician burnout.

The overall goal of any CDI program is to improve clinical documentation, coding, and reimbursement. It also aims to provide completeness, consistency, and accuracy of medical records that support the physician's judgment and medical decision making. Over the next 3 to 5 years, the CDI market is expected to witness major consolidation as merger and acquisition (M&A) activities increase among legacy EMR companies, CDI vendors, and legacy HIT vendors competing to provide pure-play solutions and capabilities on a centralized platform. The role of CDI in enabling healthcare equity will be paramount. Accurate, comprehensive, and ethnic-appropriate clinical documentation will help providers standardize reimbursement and opt for payment exceptions for specific population health management initiatives.

This will allow equitable access to quality care for all. The impact of potential regulations centered around chronic condition management (e.g., COVID-19) focused on post-pandemic care, telemedicine, and virtual care will boost CDI growth further. Integrating CDI EMR workflow tools will help vendors offer more advanced CDI and best-in-class offerings and capabilities. Outsourcing CDI skills, training, and expertise will likely continue to rise, resulting in suboptimal outcomes and staff shortages.

Table of Contents

Strategic Imperative and Growth Environment

• Strategic Imperative
• Strategic Imperative (continued)
• Growth Environment
• North American CDI Market-Key Competitors

Frost Radar™

• Frost Radar™: Clinical Documentation Improvement
• Frost Radar™: Competitive Environment

Companies to Action

• 3M Health Information Systems
• Arintra
• Cerner
• Chartwise
• EZDI (an AGS Health company)
• Greenway Health
• Nuance (part of Microsoft)
• Optum
• R1 RCM
• Waystar

Strategic Insights

• Strategic Insights

Next Steps: Leveraging the Frost Radar™ to Empower Key Stakeholders

• Significance of Being on the Frost Radar™
• Frost Radar™ Empowers the CEO's Growth Team
• Frost Radar™ Empowers Investors
• Frost Radar™ Empowers Customers
• Frost Radar™ Empowers the Board of Directors

Frost Radar™ Analytics

• Frost Radar™: Benchmarking Future Growth Potential
• Frost Radar™: Benchmarking Future Growth Potential
• Legal Disclaimer